These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8969177)

  • 41. Oxidative modification of LDL: its pathological role in atherosclerosis.
    Itabe H
    Clin Rev Allergy Immunol; 2009 Aug; 37(1):4-11. PubMed ID: 18987785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative determination of phosphatidylcholine hydroperoxides during copper oxidation of LDL and HDL by liquid chromatography/mass spectrometry.
    Hui SP; Taguchi Y; Takeda S; Ohkawa F; Sakurai T; Yamaki S; Jin S; Fuda H; Kurosawa T; Chiba H
    Anal Bioanal Chem; 2012 Jun; 403(7):1831-40. PubMed ID: 22367245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice.
    Kato R; Mori C; Kitazato K; Arata S; Obama T; Mori M; Takahashi K; Aiuchi T; Takano T; Itabe H
    Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):33-9. PubMed ID: 18988894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.
    Trpkovic A; Resanovic I; Stanimirovic J; Radak D; Mousa SA; Cenic-Milosevic D; Jevremovic D; Isenovic ER
    Crit Rev Clin Lab Sci; 2015; 52(2):70-85. PubMed ID: 25537066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxidized phosphatidylcholines are produced in renal ischemia reperfusion injury.
    Solati Z; Edel AL; Shang Y; O K; Ravandi A
    PLoS One; 2018; 13(4):e0195172. PubMed ID: 29684044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines.
    Marathe GK; Davies SS; Harrison KA; Silva AR; Murphy RC; Castro-Faria-Neto H; Prescott SM; Zimmerman GA; McIntyre TM
    J Biol Chem; 1999 Oct; 274(40):28395-404. PubMed ID: 10497200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening, expression, and characterization of an anti-human oxidized low-density lipoprotein single-chain variable fragment.
    Kumano-Kuramochi M; Fujimura T; Komba S; Maeda-Yamamoto M; Machida S
    J Biosci Bioeng; 2016 Sep; 122(3):287-93. PubMed ID: 27038672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CTP:phosphocholine cytidylyltransferase activation by oxidized phosphatidylcholines correlates with a decrease in lipid order: a 2H NMR analysis.
    Drobnies AE; van Der Ende B; Thewalt JL; Cornell RB
    Biochemistry; 1999 Nov; 38(47):15606-14. PubMed ID: 10569945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Binding and uptake of differently oxidized low density lipoprotein in mouse peritoneal macrophages and THP-1 macrophages: involvement of negative charges as well as oxidation-specific epitopes.
    Wang X; Greilberger J; Ledinski G; Kager G; Jürgens G
    J Cell Biochem; 2001; 81(3):557-69. PubMed ID: 11255238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presence of phospholipid-neutral lipid complex structures in atherosclerotic lesions as detected by a novel monoclonal antibody.
    Mori M; Itabe H; Takatoku K; Shima K; Inoue J; Nishiura M; Takahashi H; Ohtake H; Sato R; Higashi Y; Imanaka T; Ikegami S; Takano T
    J Biol Chem; 1999 Aug; 274(35):24828-37. PubMed ID: 10455155
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating oxidized LDL, measured with FOH1a/DLH3 antibody, is associated with metabolic syndrome and the coronary heart disease risk score in healthy Japanese.
    Ueba T; Nomura S; Nishikawa T; Kajiwara M; Yamashita K
    Atherosclerosis; 2009 Mar; 203(1):243-8. PubMed ID: 18635189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxidized low-density lipoprotein and high-density lipoprotein cholesterol modulate coronary arterial remodeling: an intravascular ultrasound study.
    Yoneyama S; Arakawa K; Yonemura A; Isoda K; Nakamura H; Ohsuzu F
    Clin Cardiol; 2003 Jan; 26(1):31-5. PubMed ID: 12539810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of phosphatidylcholine oxidation products in rat heart using quadrupole time-of-flight mass spectrometry.
    Adachi J; Yoshioka N; Sato M; Nakagawa K; Yamamoto Y; Ueno Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 823(1):37-43. PubMed ID: 16055051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36.
    Guy RA; Maguire GF; Crandall I; Connelly PW; Kain KC
    Atherosclerosis; 2001 Mar; 155(1):19-28. PubMed ID: 11223422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein.
    Davis B; Koster G; Douet LJ; Scigelova M; Woffendin G; Ward JM; Smith A; Humphries J; Burnand KG; Macphee CH; Postle AD
    J Biol Chem; 2008 Mar; 283(10):6428-37. PubMed ID: 18165686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation of a human standard for determination of the levels of antibodies to oxidatively modified low-density lipoproteins.
    Koskinen S; Enockson C; Lopes-Virella MF; Virella G
    Clin Diagn Lab Immunol; 1998 Nov; 5(6):817-22. PubMed ID: 9801341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phosphorylcholine-targeting immunization reduces atherosclerosis.
    Caligiuri G; Khallou-Laschet J; Vandaele M; Gaston AT; Delignat S; Mandet C; Kohler HV; Kaveri SV; Nicoletti A
    J Am Coll Cardiol; 2007 Aug; 50(6):540-6. PubMed ID: 17678738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease.
    Faviou E; Vourli G; Nounopoulos C; Zachari A; Dionyssiou-Asteriou A
    Free Radic Res; 2005 Apr; 39(4):419-29. PubMed ID: 16028367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies by EIA.
    Lopes-Virella MF; Koskinen S; Mironova M; Horne D; Klein R; Chassereau C; Enockson C; Virella G
    Atherosclerosis; 2000 Sep; 152(1):107-15. PubMed ID: 10996345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.